| Literature DB >> 24314119 |
Moa Wolff1, Kristina Sundquist, Sara Larsson Lönn, Patrik Midlöv.
Abstract
BACKGROUND: Medical treatment of hypertension is not always sufficient to achieve blood pressure control. Despite this, previous studies on supplementary therapies, such as yoga, are relatively few. We investigated the effects of two yoga interventions on blood pressure and quality of life in patients in primary health care diagnosed with hypertension.Entities:
Mesh:
Year: 2013 PMID: 24314119 PMCID: PMC4029555 DOI: 10.1186/1471-2261-13-111
Source DB: PubMed Journal: BMC Cardiovasc Disord ISSN: 1471-2261 Impact factor: 2.298
Figure 1Flow chart outlining patient recruitment and the allocation of patients to the different groups.
Baseline characteristics
| Age in years | 66.2 (7.7) | 64.0 (10.3) | 60.8 (11.0) |
| % female | 67.9 | 71.4 | 59.3 |
| BMI (kg/m2) | 29.7 (7.0) | 28.5 (7.3) | 28.8 (4.0) |
| SBP (mmHg) | 143.8 (14.9) | 143.6 (14.2) | 144.3 (14.5) |
| DBP (mmHg) | 89.0 (7.6) | 88.4 (6.2) | 89.8 (7.3) |
| On medication (%) | 96.4 | 92.9 | 85.2 |
| Well controlled (%)§ | 39.3 | 35.7 | 37.0 |
| Drugs§§ | 2.0 (1.1) | 1.8 (1.0) | 1.4 (1.0) |
| ACEI (n) | 10 | 6 | 8 |
| ARB (n) | 7 | 5 | 5 |
| Thiazides (n) | 13 | 17 | 8 |
| CCB (n) | 10 | 10 | 4 |
| BB (n) | 17 | 11 | 13 |
| Loop diuretics (n) | 0 | 1 | 1 |
| FP glucose (mmol/L) | 5.5 (0.8) | 5.4 (1.6) | 5.9 (2.3) |
| HbA1c (mmol/mol) | 40.9 (10.5) | 40.0 (8.5) | 39.6 (10.1) |
| Cholesterol (mmol/L) | 5.2 (1.0) | 5.4 (1.1) | 5.3 (1.2) |
| WHO 1† | 3.59 (0.8) | 4.07 (0.7)* | 3.96 (0.7) |
| WHO 2‡ | 3.04 (0.9) | 3.61 (0.9)* | 3.31 (0.7) |
§BP ≤140/90 mmHg at baseline.
§§Number of different antihypertensive drugs.
†WHO 1: How would you rate your quality of life? Very poor (1), poor (2), neither poor nor good (3), good (4), very good (5).
‡WHO 2: How satisfied are you with your health? Very dissatisfied (1), dissatisfied (2), neither satisfied nor dissatisfied (3), satisfied (4), very satisfied (5).
*Significant difference compared to control (p < 0.05).
SD, standard deviation; BMI, body mass index; SBP, systolic blood pressure; DBP, diastolic blood pressure; ACEI, angiotensin-converting enzyme inhibitor; ARB, angiotensin receptor blocker; CCB, calcium receptor blocker; BB, beta blocker.
BP after intervention and adjusted mean change in BP
| 144.1 (2.6) | 144.3 (3.1) | 137.0 (2.7) | 138.4 (3.2) | 141.5 (2.7) | 142.6 (3.0) | |
| Change from baseline | 0.3 (2.6) | -0.2 (3.1) | -6.8 (2.7) | -6.1 (3.2) | -2.3 (2.7) | -1.9 (3.0) |
| P-value | 0.917 | 0.954 | 0.013** | 0.061 | 0.381 | 0.527 |
| Difference vs. control | 2.6 (3.7) | 1.7 (4.3) | -4.4 (3.8) | -4.2 (4.4) | | |
| P-value | 0.482 | 0.693 | 0.241 | 0.341 | | |
| 89.4 (1.6) | 89.5 (1.9) | 84.7 (1.6) | 85.3 (1.9) | 89.9 (1.6) | 90.2 (1.8) | |
| Change from baseline | 0.2 (1.6) | 0.3 (1.9) | -4.4 (1.6) | -3.9 (1.9) | 0.8 (1.6) | 1.01 (1.8) |
| P-value | 0.889 | 0.890 | 0.008** | 0.045** | 0.612 | 0.571 |
| Difference vs. control | -0.6 (2.5) | -0.8 (2.6) | -5.2 (2.3) | -4.9 (2.6) | | |
| P-value | 0.794 | 0.771 | 0.025* | 0.064 | | |
| Yoga sessions during intervention† | 47.2 | 52.7 | 63.9 | 72.6 | ||
*Significant difference compared to control (p < 0.05).
**Significant change from baseline (p < 0.05).
†According to yoga calendar (yoga class sessions and yoga at home sessions).
OC, observed cases; PPS, per protocol set; SE, standard error of the mean; SBP, systolic blood pressure; DBP, diastolic blood pressure.
The PPS consists of all patients who (1) practiced yoga at least once a week for nine weeks or more and (2) had no change in medication during the study period.
Self-rated quality of life and self-rated health after intervention
| | | | |
| Average score | 3.98 (0.09) | 4.21 (0.09) | 3.92 (0.09) |
| Change from baseline | 0.12 (0.09) | 0.35 (0.09) | 0.06 (0.09) |
| Difference vs. control | 0.06 (0.13) | 0.29 (0.13) | |
| P-value | 0.640 | 0.027* | |
| | | | |
| Average score | 3.44 (0.11) | 3.68 (0.12) | 3.41 (0.12) |
| Change from baseline | 0.15 (0.11) | 0.39 (1.12) | 0.11 (0.12) |
| Difference vs. control | 0.04 (0.16) | 0.28 (0.16) | |
| P-value | 0.826 | 0.099 |
†For questions (WHOQOL, Items 1–2), refer to Table 1.
*Significant difference compared to the other groups (p < 0.05) (ANOVA).
OC, observed cases; SE, standard error of the mean.
Figure 2Patients’ views on the yoga practice. Patients in the yoga at home and yoga class groups were asked three questions about their experiences of the yoga. a. How did you experience the yoga practice emotionally? b. How did you experience the yoga practice physically? c. Will you continue practicing yoga after this study?